Skip to Content
Careers
Search
Search
ABOUT BIORASI
LEADERSHIP AND SCIENTIFIC ADVISORS
WHY BIORASI
PARTNERSHIP
TESTIMONIALS
THERAPEUTIC EXPERTISE
DERMATOLOGY
ONCOLOGY
NEPHROLOGY
NEUROLOGY
CELL THERAPY
FOCUSED SOLUTIONS
RESCUE & RECOVERY
DATA SCIENCES
QUALITY
FEASIBILITY
SAFETY & PHARMACOVIGILANCE
CLINICAL MONITORING
PODCAST
RESOURCE LIBRARY
CONTACT US
ABOUT BIORASI
LEADERSHIP AND SCIENTIFIC ADVISORS
WHY BIORASI
PARTNERSHIP
TESTIMONIALS
THERAPEUTIC EXPERTISE
DERMATOLOGY
ONCOLOGY
NEPHROLOGY
NEUROLOGY
CELL THERAPY
FOCUSED SOLUTIONS
RESCUE & RECOVERY
DATA SCIENCES
QUALITY
FEASIBILITY
SAFETY & PHARMACOVIGILANCE
CLINICAL MONITORING
PODCAST
RESOURCE LIBRARY
CONTACT US
Type
Article
Case Study
News
Webinar
White Paper
Topic
AI
Alzheimers
ANDA
APAC
ARTIFICIAL INTELLIGENCE
Biopharma
Biorasi Spotlight
Biosimilars
Biostatistics
Biotech
CAR T-cell
Cardiovascular Disease
CDISC Standards
CDMO
Cell Therapy
Clinical Evidence
Clinical Protocol
Clinical Research
Clinical Trials
CNS
Collaboration
Coronavirus
COVID-19
CRO
Data Management
Data Science
Data Sciences & Biometrics
Decentralization
Demographic
Dermatology
Diabetes
Digital Therapeutics
Diversity
DNA
DTx
Early Intervention
Endocrinology
Enrollment
events
Execution
FDA
FDA Approval
FIH
First-in-Human
GLP-1
Health and Wellness
Hepatocellular Carcinoma
Hepatology
Inc. 5000
India
IPF
Kidney
LSLV
Machine Learning
Medical Device
microRNA
milestones
Nephropathy
Neurodegenerative
Neurology
Neuroscience
Oncology
Ophthalmology
Parkinson’s
Patient Adherence
Patient Enrollment
Patient Outreach
Patient Recruitment
PERSONALIZED MEDICINE
Pharmacovigilance
POC
Precision Medicine
Press Releases
Program Development
Project Management
Proof-of-Concept
Pulmonary
Quotient Sciences
Rare Diseases
Real-World Evidence
Recruitment
Regenerative Medicine
Regulatory
Regulatory Reforms
Remote Solutions
Rescue
Risk Management
RNA
Safety
Semaglutide
Site Selection
Solid Tumors
Speed-to-market
Stem Cell
Study Design
TBI
Technology
Trial Rescue
U.S. Food and Drug Administration
Virtual Trials
Workflorce
Search
Article
Biorasi Welcomes Dermatologist Dr. Lawrence Green to Scientific Advisory Board
Article
Biorasi Welcomes Neurology Professor Dr. Ole Isacson to Scientific Advisory Board
Article
Biorasi: Year One
Article
Biorasi’s Wayne Bowden Takes on New Role as Vice President of Partnerships and Strategy
Article
Biorasi Welcomes Becky Knockemus as Vice President of Program Development
Article
Biorasi Kicks-Off Third COVID-19 Clinical Trial for 2020
Article
Biorasi Meets First Patient, First Visit Milestone for Dermatology Trial During COVID-19
Article
Biorasi Welcomes Scott Nenninger as Chief Financial Officer
Article
Biorasi Begins Second COVID-19 Clinical Trial of 2020
News
Biorasi Recognizes Rare Disease Day with Company-Wide Event and Fundraiser
Load more